Adeno-associated virus type 2 in children from the United States with acute severe hepatitis
Servellita, V.; Sotomayor Gonzalez, A.; Lamson, D. M.; Foresythe, A.; Huh, H. J.; Bazinet, A. L.; Bergman, N. H.; Bull, R. L.; Garcia, K. Y.; Goodrich, J. S.; Lovett, S. P.; Parker, K.; Radon, D.; Hatada, A.; Pan, C.-Y.; Rizzo, K.; Bertumen, J. B.; Morales, C.; Oluniyi, P. E.; Nguyen, J.; Tan, J.; Stryke, D.; Jaber, R.; Leslie, M. T.; Lyons, Z.; Hedman, H.; Parashar, U.; Sullivan, M.; Wroblewski, K.; Oberste, M. S.; Tate, J. E.; Baker, J. M.; Sugerman, D.; Potts, C.; Lu, X.; Chhabra, P.; Ingram, L. A.; Shiau, H.; Britt, W.; Gutierrez Sanchez, L. H.; Ciric, C.; Rostad, C. A.; Vinje, J.; Kirking
Show abstract
As of August 2022, cases of acute severe hepatitis of unknown etiology in children have been reported from 35 countries, including the United States. Here we used PCR testing, viral enrichment based sequencing, and agnostic metagenomic sequencing to analyze 27 samples, including nasopharyngeal swab, stool, plasma, and/or whole blood, from 16 such cases from 6 states (Alabama, California, Florida, Illinois, North Carolina, and South Dakota) presenting from October 1, 2021 to May 22, 2022, in parallel with whole blood samples from 45 controls. Among the 13 cases for whom whole blood was available, adeno-associated virus 2 (AAV2) sequences were detected in 92% (12 of 13) (p<0.001), while adenovirus sequences were detected in 100%, of which 11 (84.6%) were genotyped as human adenovirus type 41 (HAdV-41), one as HAdV-40, and one as HAdV-2. Co-infections of herpesviruses, Epstein-Barr virus (EBV) or human herpesvirus 6 (HHV-6), and/or enterovirus A71 (EV-A71) were also detected in all 13 cases. In contrast, AAV2 and HAdV-41 were not detected in any control, and EBV, HHV-6, or EV-A71 were each only detected in one or two of 45 controls (p<0.001). Analysis of assembled AAV2 viral genome sequences identified 35 coding mutations relative to the AAV2 reference genome, predominantly located in the VP1 capsid and assembly-activating protein (AAP) proteins, and AAV2 genomes from cases clustered together by phylogenetic analysis. Our findings of a distinct AAV2 strain in nearly all cases of acute severe hepatitis of unknown etiology in conjunction with one or more infecting helper viruses suggest that disease pathogenesis and/or severity may be related to co-infection with AAV2.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: A case report 94%
- Reservoir host studies of Lloviu virus: first isolation, sequencing and serology in Schreiber's bats in Europe 94%
- Emergence of transmissible SARS-CoV-2 variants with decreased sensitivity to antivirals in immunocompromised patients with persistent infections 94%
Similar papers in this journal
- Vaccine Breakthrough Infection with the SARS-CoV-2 Delta or Omicron (BA.1) Variant Leads to Distinct Profiles of Neutralizing Antibody Responses 93%
- Asymptomatic or mild symptomatic SARS-CoV-2 infection elicits durable neutralizing antibody responses in children and adolescents 91%
- Airway antibodies emerge according to COVID-19 severity and wane rapidly but reappear after SARS-CoV-2 vaccination 91%
Similar papers in this journal
- Reduced Pathogenicity of the SARS-CoV-2 Omicron Variant in Hamsters 92%
- Immunogenicity of convalescent and vaccinated sera against clinical isolates of ancestral SARS-CoV-2, beta, delta, and omicron variants 92%
- Rapid emergence of SARS-CoV-2 Omicron variant is associated with an infection advantage over Delta in vaccinated persons 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.